RTF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.033600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.751200E-01
Normal-vs-Stage2
4.424400E-01
Normal-vs-Stage3
9.325800E-02
Normal-vs-Stage4
9.142400E-01
Stage1-vs-Stage2
7.884200E-01
Stage1-vs-Stage3
8.712200E-02
Stage1-vs-Stage4
6.580000E-01
Stage2-vs-Stage3
1.962440E-01
Stage2-vs-Stage4
4.797800E-01
Stage3-vs-Stage4
1.775170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.980600E-01
Normal-vs-AfricanAmerican
4.466000E-01
Normal-vs-Asian
3.525600E-01
Caucasian-vs-AfricanAmerican
9.763000E-01
Caucasian-vs-Asian
5.428800E-01
AfricanAmerican-vs-Asian
7.088200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.204200E-01
Normal-vs-Female
5.305000E-01
Male-vs-Female
1.234620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.243400E-01
Normal-vs-Age(41-60Yrs)
7.913800E-01
Normal-vs-Age(61-80Yrs)
2.813400E-01
Normal-vs-Age(81-100Yrs)
1.607010E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.007200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.549600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.003000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.820500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.786200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.670400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.366600E-01
Normal-vs-Daily Drinker
3.680600E-01
Normal-vs-Weekly Drinker
4.669000E-01
Normal-vs-Occasional Drinker
4.372000E-01
Normal-vs-Social Drinker
6.059800E-01
Non Drinker-vs-Daily Drinker
7.881600E-01
Non Drinker-vs-Weekly Drinker
5.850800E-01
Non Drinker-vs-Occasional Drinker
4.197400E-01
Non Drinker-vs-Social Drinker
2.094400E-01
Daily Drinker-vs-Weekly Drinker
7.893200E-01
Daily Drinker-vs-Occasional Drinker
6.434000E-01
Daily Drinker-vs-Social Drinker
3.866000E-01
Weekly Drinker-vs-Occasional Drinker
8.879200E-01
Weekly Drinker-vs-Social Drinker
5.967600E-01
Occasional Drinker-vs-Social Drinker
6.460800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.439020E-01
Normal-vs-Grade 2
1.981560E-02
Normal-vs-Grade 3
1.389980E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.653900E-02
Grade 1-vs-Grade 3
1.631840E-02
Grade 1-vs-Grade 4
1.439020E-01
Grade 2-vs-Grade 3
2.810200E-01
Grade 2-vs-Grade 4
1.981560E-02
Grade 3-vs-Grade 4
1.389980E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.334400E-01
Normal-vs-NonDiabetic
3.586200E-01
Diabetic-vs-NonDiabetic
2.712800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.828000E-01
Normal-vs-NoPancreatitis
3.423400E-01
Pancreatitis-vs-NoPancreatitis
3.490200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.338800E-01
Normal-vs-N1
4.695200E-01
N0-vs-N1
4.238600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.638400E-01
Normal-vs-TP53-NonMutant
4.494000E-01
TP53-Mutant-vs-TP53-NonMutant
9.163900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
